Top Buy
| Security | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Lexicon Pharmaceuticals Inc. | 2 | 0 | 0 | 0 | €1.76 | €5.34 | 203.010% |
| Immunogen Inc. | 4 | 0 | 0 | 0 | €28.97 | - | - |
| Rigel Pharmaceutical Inc. | 11 | 0 | 1 | 0 | €0.87 | €13.78 | 1475.300% |
| Actinium Pharmaceuticals Inc. | 3 | 0 | 0 | 0 | €7.45 | €8.50 | 14.171% |
| Puma Biotechnology Inc. | 2 | 0 | 1 | 0 | €3.25 | €10.00 | 207.882% |
| Avadel Pharmaceuticals plc ADR | 1 | 0 | 0 | 0 | €15.10 | €23.00 | 52.318% |
| MacroGenics Inc. | 13 | 0 | 3 | 0 | €4.26 | €12.42 | 191.660% |
| Biocryst Pharmaceuticals | 9 | 0 | 0 | 0 | €6.06 | €11.05 | 82.177% |
| Fagron N.V. | 1 | 0 | 0 | 0 | €18.72 | €20.00 | 6.838% |
| Ardelyx Inc. | 2 | 0 | 0 | 0 | €6.01 | €11.00 | 83.089% |
| Astellas Pharma Inc. | 2 | 0 | 1 | 0 | €9.40 | €16.00 | 70.285% |
| Esperion Therapeutis.Inc. | 15 | 0 | 1 | 0 | €2.71 | €8.55 | 215.565% |
| Adverum Biotechnologies Inc. | 7 | 0 | 1 | 0 | €1.38 | €5.60 | 305.913% |
| Biolife Solutions Inc | 1 | 0 | 1 | 0 | €18.80 | - | - |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €66.74 | €100.00 | 49.835% |
| Rhythm Pharmaceuticals | 15 | 0 | 0 | 0 | €38.20 | €45.98 | 20.366% |
| Catalyst Pharmaceutical Partners Inc | 14 | 0 | 3 | 0 | €14.52 | €24.13 | 66.207% |
| Trinity Biotech ADR | 25 | 0 | 3 | 0 | €0.41 | - | - |
| Verastem Inc. | 12 | 0 | 5 | 0 | €3.10 | €19.90 | 541.990% |
| Xeris Biopharma Holdings Inc. | 6 | 0 | 1 | 0 | €2.16 | €4.39 | 103.301% |
| Dynavax Technologies Corp | 2 | 0 | 0 | 0 | €11.22 | €26.95 | 140.193% |
| Clinuvel Pharmaceuticals | 1 | 0 | 0 | 0 | €8.90 | - | - |
| Intra-Cellular Therapies Inc. | 25 | 0 | 1 | 0 | €64.50 | €79.55 | 23.340% |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.60 | - | - |
| Faes Farma S.A. | 1 | 0 | 0 | 0 | €3.80 | €6.00 | 57.895% |